Research Article
Danshen (Salvia miltiorrhiza) Compounds Improve the Biochemical Indices of the Patients with Coronary Heart Disease
Table 1
Baseline characters of CHD patients.
| | Characteristic | Danshen () | Control () | values |
| | Age (years) | 65.9 ± 5.7 | 67.1 ± 6.4 | 0.269 | | Gender, male (%) | 26 (41.3) | 24 (38.1) | 0.716 | | Hypertension | | | | | Systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg (%) | 48 (76.2) | 50 (79.4) | 0.668 | | Hypercholesterolemia (>200 mg/dL) (%) | 21 (33.3) | 22 (34.9) | 0.851 | | Diabetes mellitus (%) | 17 (27) | 14 (22.2) | 0.535 | | BMI (kg/m2) | 25.2 ± 5.6 | 25.8 ± 5.4 | 0.541 | | Cigarette smokers (%) | 31 (49.2) | 29 (46) | 0.721 | | Chronic kidney disease (%) | 2 (3.2) | 1 (1.6) | 1.000 | | Clinical presentation | | | | | Unstable angina (%) | 37 (58.7) | 34 (54) | 0.590 | | Non-ST-segment elevation myocardial infarction (%) | 11 (17.5) | 13 (20.6) | 0.650 | | ST-segment elevation myocardial infarction (%) | 12 (19) | 14 (22.2) | 0.660 |
|
|
